Acceleron  

Publications

Oral Presentation – The DART Study: Part 1 results of dose escalation and expansion cohorts of dalantercept plus axitinib in advanced renal cell carcinoma. American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium. February 28, 2015
+ DOWNLOAD PDF

Interview with Dr. Martin Voss, Memorial Sloan Kettering Cancer Center, on Part 1 of the DART study (click here to access video)